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Abstract
Background: The combination of elevated glucose and free-fatty acids (FFA), prevalent in diabetes, has been suggested to
be a major contributor to pancreatic b-cell death. This study examines the synergistic effects of glucose and FFA on b-cell
apoptosis and the molecular mechanisms involved. Mouse insulinoma cells and primary islets were treated with palmitate at
increasing glucose and effects on apoptosis, endoplasmic reticulum (ER) stress and insulin receptor substrate (IRS) signaling
were examined.
Principal Findings: Increasing glucose (5–25 mM) with palmitate (400 mM) had synergistic effects on apoptosis. Jun NH2-
terminal kinase (JNK) activation peaked at the lowest glucose concentration, in contrast to a progressive reduction in IRS2
protein and impairment of insulin receptor substrate signaling. A synergistic effect was observed on activation of ER stress
markers, along with recruitment of SREBP1 to the nucleus. These findings were confirmed in primary islets. The above
effects associated with an increase in glycogen synthase kinase 3b (Gsk3b) activity and were reversed along with apoptosis
by an adenovirus expressing a kinase dead Gsk3b.
Conclusions/Significance: Glucose in the presence of FFA results in synergistic effects on ER stress, impaired insulin
receptor substrate signaling and Gsk3b activation. The data support the importance of controlling both hyperglycemia and
hyperlipidemia in the management of Type 2 diabetes, and identify pancreatic islet b-cell Gsk3b as a potential therapeutic
target.
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Introduction
The natural history of Type 2 diabetes mellitus (T2D) includes
a progressive decline in b-cell function associated with peripheral
insulin resistance. The b-cell dysfunction has been attributed in
part to loss of b-cell mass via apoptosis [1] with inadequate
insulin secretion leading to hyperglycemia and other diabetes
symptoms [2]. Insulin resistance is at the core of obesity
associated diabetes and is thought to reflect impaired insulin
signaling due to chronically increased levels of free fatty acids
(FFA). High FFA are also implicated in the reduction in b-cell
mass that has been referred to as lipotoxicity. The combination of
elevated glucose and FFA, or ‘‘glucolipotoxicity’’ that is prevalent
in T2D has been suggested to be a major contributor to b-cell
death [3,4,5,6].
The search for molecular mechanisms for glucose potentiation
of FFA- induced b-cell dysfunction has been the subject of several
recent studies (see [7] for review). One area of investigation has
focused on the insulin receptor substrate-PI3K-Akt signaling
pathway. The first study showing that the FFA oleate impaired
insulin signaling in insulinoma cells demonstrated that the cells
were protected from FFA-induced apoptosis by expressing a
constitutively active Akt [8]. Several biochemical and genetic
studies subsequently showed that saturated FFA could promote
ER stress in insulinoma cells and in primary rodent and human
islets [9,10,11,12]. More recently, it was shown that high glucose
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ER stress in insulinoma cells was shown to impair insulin signaling
through activation of ATF3, an ER stress response protein that
was implicated in suppression of IRS2 expression [14]. ATF3 is
another stress inducible gene that is activated in different tissues by
a variety of stresses [15].
How glucose potentiates FFA induced ER stress, reduced
insulin receptor substrate signaling, and apoptosis is incompletely
understood. Our recent study showed that there was a dose-
dependent effect of FFA in the presence of high glucose on
apoptosis in insulinoma cells and primary islets [16] that was
associated with JNK activation, ER stress, and reduced insulin
signaling. In the current study, we found a dose-dependent effect
of glucose in the presence of palmitate on cell death that
appeared to be over and above JNK activation. We observed
glucose dose-dependent synergistic effects on palmitate inhibi-
tion of receptor substrate signaling and activation of Gsk3b.C o -
treatment with an adenovirus expressing a kinase dead Gsk3b
significantly protected b-cells from cell death. Our data support
importance of Gsk3b in the synergistic effects of glucose and
FFA.
Materials and Methods
Cell Culture
Mouse insulinoma cell line MIN6 (passage 24–32) were grown
in monolayer cultures as described previously [17] in Dulbecco’s
modified Eagle’s medium (Sigma Aldrich) supplemented with 15%
fetal bovine serum, 50 mmol/L b-mercaptoethanol at 37uCi na
humidified (5% CO2, 95% air) atmosphere. Rat insulinoma INS-
r3 cells were grown as previously described [18]. The palmitic acid
(palmitate), formalin, propidium iodide, IL-1b, tunicamycin and
TNFa were purchased from Sigma (Saint Louis, MO). Taur-
oursodeoxycholic Acid Sodium Salt (TUDCA) was purchased
from CALBIOCEM (Darmstadt, Germany).
Fatty acids (FFA) Treatment of MIN6 Cells and Islets
The complete protocol was previously described [16]. Briefly a
20 mM solution of the FFA in 0.01 M NaOH was incubated at
70uC for 30 minutes. Then, 330 mL of 30% BSA and 400 mLo f
the free FFA/NaOH mixture was mixed together and filter
sterilized with 20 mL of either the DMEM or RPMI media. The
approximate molar ratio of FFA:BSA is 6:1 with 400 mM
palmitate. The addition of BSA or a FFA:BSA mixture has not
been shown to affect the pH of the media.
Propidium iodide/Cell Death Assay
MIN6 cells were grown on glass cover slips within the wells of a
6-well plate and incubated with either BSA alone or 400 mM both
FFAs complexed with BSA for 24 hours as previously described
[16]. After treating cells for 24 hours with various treatments, the
cells were incubated with 10 mg/ml (1 to 1000 dilution) Propidium
Iodide (PI) and 20 ug DAPI added directly to the media at 37uC,
5% CO2 for 1 hour. The medium was then removed by
aspiration, and the cells were washed once with PBS and then
fixed by incubation with 3.7% formaldehyde for 15 min at room
temperature. After fixation, the MIN6 cells were mounted with
anti-fading gel solution including DAPI (Biomeda Corporation,
Foster City, CA) on to glass slides. Each condition reported
represents over 3000 cells counted by randomized field selection.
The percentage of cell-death is reported as the number of PI
stained nuclei over the total number of nuclei stained by DAPI as
quantitated by Image J software 1.37 [19].
Western blot analysis
MIN6 were washed twice in ice-cold phosphate-buffered saline
and were lysed in ice-cold cell lysis buffer consisting of 50 mM
HEPES (pH 7.5), 1% (v/v) Nonidet P-40, 2 mM activated sodium
orthovanadate, 100 mM sodium fluoride, 10 mM sodium pyro-
phosphate, 4 mM EDTA, 1 mM phenylmethylsulfonyl fluoride,
1 mg/mL leupeptin, and 1 mg/mL aprotinin, then passed through
syringe with a 21 gauge needle 10 times while INS-r3 cells were
sonicated (Misonix, Farmingdale, NY) and particulate material
from both cell lines were removed by centrifugation (10,0006g;
10 min; 4uC). The supernatants were collected. Protein concen-
trations were determined using the Bio-Rad protein assay (Bio-
Rad, Hercules, CA).
The extracts (20 mg of total protein) were resolved on 7.5% or 4–
15% gradient polyacrylamide gels and were blotted onto a
nitrocellulose membrane (Bio-Rad, CA), and incubated overnight
at 4uC in Tris-buffered saline containing a 1:1000–5000 dilution of
antibody as listed below. The membrane was then incubated at 4uC
for 60 min in Tris-buffered saline with a 1:2000 dilution of anti-
rabbit IgG or anti-mouse IgG horseradish peroxidase-conjugated
secondary antibody (Cell Signaling Technology). Antibodies used
were anti-total Akt, anti-phospho-Akt (S473), anti-cleaved Cas-
pase3, anti-phospho-PERK (980Thr), anti-phospho-eIF2a(51Ser),
anti-total JNK1/2, anti-phospho-JNK, anti-phospho-AMPK, total
AMPK, anti-phospho-ACC, anti-total ACC from Cell Signaling
Technology (Beverley, MA), anti-SREBP1 from Neo Markers
(Fremont, CA), anti-IRS1, anti-IRS2 from Upstate (Billerica, MA),
anti-ATF3, anti-Insig1, anti-Lamin from Santa Cruz (Santa Cruz,
CA) and anti-a-Tubulin and from Sigma (Saint Louis, MO).
Immune complexes were revealed using ECL Advance Western
Blot Detection kit (Amersham Plc, Buckinghamshire UK) and the
images were acquired using a FluoroChem 8800 digital camera
acquisition system (Alpha Innotech, San Leandro, CA, USA).
Band intensities in the blots were later quantified using ImageJ
1.386[19] and a-Tubulin or b-Actin bands were used to adjust
for loading differences.
Nuclear and cytoplasmic fractions from MIN6
MIN6 cells were cultured in 60-mm diameter culture dishes until
80% confluency. For isolation of nuclear extracts, the cells were
then collected into microtubes, centrifuged for 20 s in a micro-
centrifuge, and resuspended in 200 ml of 10.0 mM Hepes, pH 7.9,
containing 10.0 mM KCl, 1.5 mM MgCl2, and 0.5 mM dithio-
threitol. After incubation at 4uC for 15 min, the cells were lysed by
passing 10 times through a 21-gauge needle. Next, the cells were
centrifuged for 20s in a microcentrifuge, and the supernatant
(cytoplasmic fraction) was removed and frozen in small aliquots.
The pellet, which contained the nuclei, was resuspended in 150 ml
of 20 mM Hepes, pH 7.9, containing 20% v/v glycerol, 0.1 M
KCl, 0.2 mM EDTA, 0.5 mM dithiothreitol, and 0.5 mM
phenylmethanesulfonyl fluoride and then stirred at 4uC for
30 min. The nuclear extracts were then centrifuged for 20 min at
4uC in a microcentrifuge. The supernatant was collected, aliquoted
into small volumes, and stored at 280uC.
Islet isolation and culture
Islets from 12 weeks of age C57BL/6 male mice were isolated
by ductal collagenase distension/digestion of the pancreas [20]
followed by filtering and washing through a 70 mm Nylon cell
strainer (BD Biosciences, San Jose, CA). Isolated islets were then
maintained in RPMI medium containing 11 mM glucose, 10%
FBS, 200 units/ml penicillin, and 200/ml streptomycin in
humidified 5% CO2, 95% air at 37C. The palmitate treatments
were carried out 15 hours after isolation. Adenovirus infections
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infection (MOI). Infections were incubated for 15 hours and
residual virus was removed prior to palmitate treatment. All
procedures were performed in accordance with Washington
University’s Animal Studies Committee. The Principles of
laboratory animal care (NIH publication no. 85–23, revised
1985; http://grants1.nih.gov/grants/olaw/references/phspol.htm)
were followed.
Loss-of-function of ATF3 with shATF3
INS-r3 cells were seeded 24 hours prior to infection to achieve
70 percent confluence at time of infection. Control and ATF3
Figure 2. Glucose and palmitate potentiate to reduce insulin signaling. MIN6 cells were treated with either control 0.5% BSA (four lanes on
left) or 400 mM palmitate+0.5% BSA (four lanes on right) at a concentration of 5, 10, 15, 25 mM glucose for 24-h. Total cell lysates were obtained and
were subjected to Western blot analysis with antibodies to the indicated proteins. Protein level of IRS2 was normalized over a-Tubulin. The
representative results of three individual experiments are shown. The results for IRS2 are graphically illustrated, data are expressed as means 6S.E.M.
*p,0.05, **p,0.01.
doi:10.1371/journal.pone.0018146.g002
Figure 1. Synergistic effects of glucose and palmitate on cell death but not JNK activation in MIN6 cells. MIN6 cells were treated with
either control 0.5% BSA or 400 mM palmitate+0.5% BSA at a concentration of 5, 10, 15, 25 mM glucose for 24-h. (A) The percentage of cell death was
then assessed by adding propidium iodide for the last hour of incubation as described under Methods. The bar graph depicts the averages of the
data obtained from five individual experiments, and data are expressed as means 6S.E.M. ** p,0.01, *** p,0.001; (B) The cell lysates were subjected
to Western blot analysis using anti-cleaved Caspase3, anti-phospho-JNK, anti-total JNK and anti-a-Tubulin antibodies. Protein level of phospho-JNK
was normalized over total JNK. Cleaved Caspase3 levels were normalized over a-Tubulin. The representative result of three individual experiments is
shown. The data obtained from three individual experiments are expressed as means 6 S.E.M. * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0018146.g001
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of a chemical chaperon. (A) MIN6 cells were treated with either control 0.5% BSA or 400 mM palmitate+0.5% BSA at a concentration of 5, 10,
25 mM glucose for 8 hours. Total cell lysates were extracted at indicated time points and were subjected to Western blot analysis using anti-
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incubated with the cells at an MOI of 30 for 4 hours in normal
culture media. Palmitate and cytokine treatments were initiated
24 hours following removal of virus.
Inhibition of Gsk3b expression with a kinase dead
adenovirus
Adenovirus expressing a catalytic inactive mutant of the human
Gsk3b (Adv-Gsk3bKM) was prepared as previously described
[21]. Control adenovirus-green fluorescent protein (AdV-GFP)
was a gift from D. Kelly (Washington University, St. Louis, MO).
Infection of the MIN6 cells was carried out at the indicated
multiplicity of infection (MOI) for one hour in serum-free media.
The MIN6 were then washed in PBS, maintained in the DMEM/
15% FBS media, and then experiments were carried out 24 hours
after infection.
Statistical analysis
The presented data were analyzed from at least 3 independent
experiments and are shown as means 6S.E.M. The significance of
the variations was analyzed using either a one- or two-way
ANOVA with Bonferroni corrections with a significance level of
0.05 (95% confidence intervals).
Results
Glucose and palmitate synergize to induce apoptosis
Our previous study had shown a dose-dependent effect of FFA,
both palmitate (50–400 mM) and oleate (50–400 mM), on ER stress
and apoptosis in glucose-responsive insulinoma (MIN6) cells [16].
In the current study the dose-dependent effect of glucose (5–
25 mM) was examined at 400 mM palmitate. As shown in
Figure 1A, increasing glucose concentration had a clear synergistic
effect on cell death characterized by propidium iodide incorpo-
ration normalized to DAPI staining. While 400 mM palmitate
resulted in about 3% propidium iodide incorporation at 5 mM
glucose, this was increased more than threefold when the glucose
concentration was raised to 15 mM and 25 mM. While there was
no effect of palmitate on cleaved Caspase3 at 5 mM glucose,
consistent with the synergism observed on propidium iodide
staining, glucose and palmitate also synergized on activation of
the pro-apoptotic marker cleaved Caspase3 comparing that at
5 mM glucose/palmitate vs. 25 mM glucose/palmitate, p,0.05
(Figure 1B).
We next explored the underlying mechanisms for the glucose
potentiation. FFA treatment has been shown to induce JNK
activation that can contribute to FFA-induced apoptosis; we
determined the effects of altering glucose concentrations on JNK
activation. Interestingly, JNK activation by FFA was maximal at
the lowest glucose concentration and did not increase further as
glucose was increased (Figure 1B). Maximal FFA activation of
JNK at 5 mM glucose with apparent increasing activation of
cleaved Caspase3 with increasing glucose concentration suggested
that further enhancement of JNK by glucose could not explain the
synergistic effects on cell death.
Glucose and palmitate synergize to reduce insulin
signaling associated with a decrease in IRS2 protein
Previous studies have shown that glucose treatment of
insulinoma cells results in activation of the insulin receptor
substrate-PI3-kinase-Akt pathway that serves to protect against b-
cell death. In contrast, FFA treatment of insulinoma cells inhibits
this pathway [8,16]. We examined whether the synergistic effect of
glucose on FFA-induced apoptosis could be related to inhibition of
this signaling pathway. Glucose alone (5–25 mM), as shown in the
first four lanes of Figure 2, increased phospho-Akt (S473) and
phospho-Gsk3 as expected, with no apparent change in IRS1 or
IRS2 proteins, confirming previous observations [8,22]. However
as glucose was raised in the presence of palmitate (Figure 2, lanes
5–8) a dose-dependent decrease in phospho-Akt and phospho-
Gsk3b were observed and accompanied by a parallel decrease in
IRS2, while IRS1 levels did not appear to change. This synergistic
effect of increasing glucose in the presence of FFA on inhibition of
IRS2 and PI-3 kinase-Akt signaling is a novel finding that might
explain the synergistic effect on b-cell survival [23].
The effect of glucose and FFA is accompanied by a
synergistic effect on ER stress that is reduced by addition
of a chemical chaperone
FFA impair insulin signaling in b-cells in part via activation of
ER stress [16,24]. Bachar et. al. [13] recently showed in
insulinoma cells that palmitate at 22.2 mM glucose vs. 3.3 mM
glucose increased activation of JNK, CHOP and the ER stress
enzyme phospho-PERK. We examined the effects of increasing
glucose from 5 mM to 25 mM at 8 and 18 hours of treatment to
observe the different time course of development of ER stress
markers. An enhancement of the ER stress markers phospho-
PERK, phospho-eIF2a, CHOP, and ATF3 (Figure 3A and 3B)
was observed, confirming and extending the results of Bachar
et. al. [13]. The observation that glucose appeared to synergize
with palmitate to increase ATF3 protein expression, although this
was not statistically significant, was consistent with the previous
finding by Hartman et. al. demonstrating that high glucose and
FFA together increased ATF3 mRNA expression, and that this
was associated with increased apoptosis of insulinoma cells [25].
These glucose-induced changes in the presence of palmitate on ER
stress markers were again noted in the absence of phospho-c-Jun
(Figure 3C).
We next examined whether reducing ER stress using TUDCA,
a chemical chaperone that enhances ER functional capacity [26],
phospho-PERK (980Thr), anti-phopsho-eIF2a (51Ser), and (B) MIN6 cells were treated with either control 0.5% BSA or 400 mM palmitate+0.5% BSA at a
concentration of 5, 10, 25 mM glucose for 18 hours and blotted with anti-ATF3 and anti-CHOP antibodies. b-Actin was detected for loading control.
Tunicamycin treatment was control for ER stress. (C) Cells were treated with either 500 mg/ml NaCl (ionic control) or 500 mg/ml TUDCA 15-h prior to
beginning of palmitate treatment and then were co-treated with either 0.5% BSA or 400 mM palmitate+0.5% BSA with either 5 mM or 25 mM glucose
and NaCl or TUDCA for 24 h. Total cell lysates were subjected to Western blot analysis with antibodies to the indicated proteins. Densitometry of total
CHOP and cleaved Caspase3 and Pdx1 were measured and normalized over a-Tubulin, respectively. Densitometry of phospho-cJun was measured
and normalized over total JNK. The representative results of three individual experiments are shown. The effects on CHOP, cleaved Caspase3 and
phospho-cJun and Pdx1 protein are graphically illustrated. *p,0.05. (D) Cells were treated with either 500 mg/ml NaCl (ionic control) or 500 mg/ml
TUDCA 15-h prior to beginning of palmitate treatment and then were co-treated with either 0.5% BSA or 400 mM palmitate+0.5% BSA with either
5 mM, 10 mM or 25 mM glucose and NaCl or TUDCA for 24-h. Total cell lysates were subjected to Western blot analysis with antibodies to the
indicated proteins. Densitometry of total IRS2 was measured and normalized over a-Tubulin and densitometry of phospho-Akt was measured and
normalized over total Akt. The representative results of three individual experiments are shown. The effects on IRS2 protein are graphically illustrated,
*p,0.05, **p,0.01.
doi:10.1371/journal.pone.0018146.g003
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PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e18146Figure 4. The synergistic effects of glucose and palmitate on ER stress results in concomitant effects on activation of SREBP1. (A)
MIN6 cells were treated with either control 0.5% BSA or 400 mM palmitate+0.5% BSA at a concentration of 5, 10, 15, 25 mM glucose for 18-h. Nuclear
fractions were extracted from the cells and were subjected to Western blot analyses using anti-SREBP1 and anti-Lamin antibodies. 25 mg of nuclear
protein was loaded in each lane. The upper band normalized over Lamin was used to do the quantification (the lower band is nonspecific). The
relative ratio of nuclear SREBP1 over Lamin calculated by densitometries was summarized as means 6 S.E.M. in the graph respectively. The
representative results of three experiments are shown, and graphically illustrated, * p,0.05. (B) MIN6 cells were treated with either control 0.5% BSA
or 400 mM palmitate+0.5% BSA at a concentration of either 5 or 25 mM glucose for 24-h. Total cell lysates were subjected to Western blot analysis
using anti-acetyl CoA carboxylase (ACC) and anti-a-Tubulin antibodies. The representative results of two individual experiments are shown. (C) Cells
were treated with either 500 mg/ml NaCl or 500 mg/ml TUDCA 15-h prior to beginning of palmitate treatment. Cells were co-treated with either 0.5%
BSA or 400 mM palmitate+0.5% BSA with 25 mM glucose and NaCl or TUDCA for 18-h. Nuclear fractions were extracted from the cells and were
subjected to Western blot analyses using anti-SREBP1 and anti-Lamin antibodies. The upper band normalized over Lamin was used to do the
quantification (the lower band is nonspecific). 25 mg of nuclear extracts were loaded in each lane. The representative results of three individual
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receptor substrate signaling. As shown in Figure 3C, the effects of
24 hour treatment with 5 mM or 25 mM glucose in the presence
and absence of palmitate (400 mM) on activation of JNK and other
markers of ER stress are shown in the control condition with NaCl
(first 4 lanes). The results of protein expression under the same
conditions but in the presence of TUDCA are shown in the last 4
lanes of Figure 3C. JNK activation, which again was not
augmented by the combination of high glucose and palmitate,
was little affected by TUDCA treatment. In contrast the other ER
stress markers phospho-eIF2a, CHOP and cleaved Caspase 3
were attenuated by co-treatment with TUDCA. Addition of
TUDCA also increased Pdx1 (Figure 3C). The increase in
phospho-Akt protein levels, an inhibitor of Gsk3 activity, and
IRS2 protein levels were also observed with TUDCA treatment
(Figure 3D). Together the results suggest that glucose potentiation
of FFA induced apoptosis involves activation of ER stress with
resultant inhibition of insulin signaling in a manner independent of
further JNK activation.
Glucose and palmitate synergistically activate SREBP1
Sterol regulatory element-binding protein-1 (SREBP1) is a
transcription factor that stimulates expression of lipid-regulatory
genes [27]. SREBP1 is an ER membrane resident protein that in
response to sterol depletion is cleaved to generate a transcription-
ally active N-terminal fragment that translocates to the nucleus
[28]. SREBP1 is increased in liver and islets of diabetic animals
[29]. In vivo SREBP1 overexpression increased lipid accumulation
in islets, reduced b-cell mass, and impaired insulin secretion [30].
Overexpression of the SREBP1 gene in insulinoma and islet b-
cells also reduced IRS2 protein [31]. Furthermore, incubation of
insulinoma cells and islets with high glucose (25 mM) was shown
to activate SREBP1. The latter study examined only high glucose,
and did not include FFA. As shown in Figure 4A, like the study of
Wang et. al [31] we observed an apparent slight effect of
increasing glucose on SREBP1 activation, when nuclear SREBP1
was corrected for nuclear Lamin. A synergistic effect was observed
of glucose and FFA on activation of SREBP1 with a concomitant
reduction of SREBP1 precursor and appearance of mature or
nuclear SREBP1. SREBP1 activation was further confirmed by
increased expression of its target acetyl-CoA carboxylase (ACC)
(Figure 4B). SREBP1 activation was reduced by attenuation of ER
stress with TUDCA pretreatment (Figure 4C) that suggested that
the synergistic effects of glucose and palmitate on activation of
SREBP1 were mediated by exacerbation of ER stress.
Glucose/palmitate activate ER stress and reduce insulin
signaling in primary islets
To validate the relevance of synergistic effects of glucose and
palmitate on pancreatic b-cells we treated isolated primary mouse
islets with 11 mM or 30 mM glucose in either the absence or
presence of 400 mM palmitate for 72 hours. This incubation time
and different glucose concentrations were utilized as it was
determined that primary islets are more resistant to FFA induced
apoptosis than are insulinoma cells (data not shown). Treatment
with high glucose (30 mM) and palmitate resulted in an apparent
but not significant (p=0.14) enhanced induction of cleaved
Caspase3 (Figure 5A), and an apparent but not significant
(p=0.07) reduced IRS2 expression (Figure 5B). In addition, high
glucose and palmitate synergistically enhanced the ER stress
marker GRP78 (p,0.05) beyond JNK activation (Figure 5C), and
caused an apparent increase in ATF3 (p=0.06) (Figure 5D).
Consistent parallel increases in nuclear SREBP1 and total ACC
protein also appeared to be potentiated by high glucose and
palmitate although the effects were not significant (Figure 5E).
Treatment with high glucose and palmitate did however result in
significant reduction of phospho-Akt, Pdx1, and phospho-Gsk3b
with no change in phospho-cJun (Figure 5F). These data together
support the relevance of findings in insulinoma cells to primary
islet b-cells.
Loss-of-function of ATF3 and gain-of function of IRS2
reduce the effects of glucose and palmitate on apoptosis
To assess the effects of ER stress-induced ATF3 expression and
subsequent suppression of IRS2 on glucolipotoxicity mediated
apoptosis, loss- and gain-of-function studies were conducted. INS-
r3 cells were utilized as the reagents for small hairpin RNA
(shATF3) were controlled for rat ATF3 and not mouse. A similar
role for ATF3 in MIN6 and INS1 insulinoma cell stress response
has been observed (Zmuda and Hai, unpublished observations).
INS-r3 cells were incubated with 400 mM palmitate/25 mM
glucose for the indicated times in the presence of adenoviruses
expressing either control or shATF3 to reduce ATF3 expression
[14]. Note that phospho-Akt appeared to be elevated in cells
expressing shATF3 at all times consistent with the known
inhibitory effect of ATF3 on IRS2 transcription and subsequent
insulin signaling. The IRS2 levels in the ATF3 knockdown cells
appeared to be elevated relative to that in control cells at both 8
and 16 hours of glucose/palmitate treatment. Further cleaved
Caspase3, following glucose/palmitate treatment, was suppressed
in ATF3 knockdown cells (p,0.002). The conclusion that ER
stress activates ATF3 that contributes to impaired insulin signaling
and apoptosis is thus supported by these ATF3 knockdown
experiments.
In another experiment using primary islets treated with glucose/
palmitate for 72 hours, the effects of transfection with an
adenovirus expressing IRS2 was compared to that of islets with
control adenovirus. As shown in Figure 6B, where Immunodetec-
tion was set to assess high levels of IRS2 in IRS2 transfected cells,
there was a marked increase in IRS2 protein with IRS2
overexpression. Glucose/palmitate treatment resulted in increased
ATF3 and cleaved Caspase3 with control adenovirus, while
overexpression of IRS2 appeared to reduce the degree of apoptosis
as measured by reduction of cleaved Caspase3 (Figure 6B). These
results are consistent with the previously demonstrated role of
ATF3 on ER stress induced apoptosis in islets [14,25].
Loss-of-function of Gsk3b on glucose and palmitate
induced b-cell apoptosis
The progressive decline in insulin receptor substrate signaling
observed with decreasing IRS2 expression and phospho-Akt was
associated with decreased phosphorylation of Gsk3b (Figure 2) and
thus activation of the pro-apoptotic form of Gsk3b [32]. To
examine the contribution of activation of Gsk3b, the effects of
palmitate treatment with increasing amounts of an adenovirus
expressing a catalytic inactive mutant of the human Gsk3b (Adv-
Gsk-3bKM) were analyzed by Western blot (Figure 7A). A control
sample was placed on either end of the blot to facilitate
experiments are shown. The relative ratio of nuclear SREBP1 over Lamin calculated by densitometries was summarized as means 6 S.E.M. in the
graph respectively **p,0.01.
doi:10.1371/journal.pone.0018146.g004
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PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e18146Figure 5. Synergistic effects of glucose and palmitate on ER stress and suppression of IRS2 expression levels in primary mouse
islets. Islets from 14 weeks of age C57BL/6 male mice were isolated as described in Methods and were treated with either control 0.5% BSA or
400 mM palmitate+0.5% BSA in RPMI medium containing either 11 mM or 30 mM glucose, 10% FBS for 72-h. Total cell lysates were extracted from
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Caspase3 and phopho-JNK between the two controls on either
end of the blot. Increasing doses of the virus correlated with
increased levels of total Gsk-3b, and reduced levels of the Gsk-3b
substrate phospho-GS. Increased kinase dead Gsk-3b virus also
resulted in increased expression of Pdx1, reduced apoptosis as
suggested by cleaved Caspase 3 levels, and cell death measured by
propidium iodide incorporation (Figure 7B). Interestingly the
protective effects of the Adv-Gsk-3bKM occurred in spite of
apparent comparable activation of phospho-JNK with palmitate
treatment.
Discussion
The combination of hyperglycemia and hyperlipidemia that is
associated with insulin resistance may contribute to reducing b-cell
mass and promoting the transition to full blown Type 2 diabetes,
but the underlying mechanisms are only partially understood. This
study examined the sequence of molecular events that may be
involved in this process, and resulted in several novel observations:
1) While early induction of JNK plays a role in FFA-induced
apoptosis [13,16], it does not appear involved in the high glucose
potentiation of FFA effects; 2) the potentiating effects of glucose
and FFA on ER stress result in activation of ER-associated
SREBP1 and ATF3 leading to reduced IRS2 expression further
impairing insulin-receptor substrate-PI-3K-Akt signaling, and 3)
treatment with an adenovirus expressing a kinase dead Gsk3b
significantly restored Pdx1 levels, and reduced the apoptosis
induced by high glucose and FFA. Together these findings provide
a molecular model for the synergistic effects of glucose and FFA on
islet cell death and identify potentially useful therapeutic targets.
The role of JNK activation in FFA-induction of apoptosis in b-
cells has been documented [13,16,33]. In the current study, JNK
activation by palmitate was significant as expected, but was
maximal at low glucose, and glucose potentiation of FFA-induced
apoptosis was JNK independent (Figure 1B). How FFA treatment
of b-cells leads to JNK activation is not completely known, but
FFA induce ER stress, which activates JNK activation, and JNK
activation itself can induce ER stress [13,34]. Interestingly,
TUDCA appeared to reduce cleaved Caspase3 and CHOP
induction, while not appearing to reduce JNK activation (Figure 3)
suggesting that in this case JNK activation is upstream of ER
stress. On the other hand the results of inhibition of ATF3 by
shRNA in Figure 6A suggest that JNK activation is upstream of
ER stress. Our results do not therefore settle this issue of the
relative position of JNK activation and ER stress. Regardless of
whether JNK activation is upstream or downstream of ER stress,
the findings in the current study show that the combination of high
glucose and FFA does not associate with further activation of JNK
as compared to FFA in low glucose. This result is to some extent in
conflict with that of Bachar et. al. [13] who showed that incubating
islet cells in low vs. high glucose resulted in both increased ER
stress and JNK activation. A difference in the two experiments is
that Bachar et.al. evaluated islet cells in 3.3 mM vs. 22 mM
glucose, and our experiments assessed cells in 5.5 mM vs. 25 mM
glucose. Our results do not rule out the contributory effect of JNK
on b-cell apoptosis as previously shown [13,16,33] but they
emphasize the importance of additional mechanisms contributed
by high glucose. Additionally, since glucose and palmitate have
been shown to evoke oxidative stress, impairing nuclear translo-
cation of Pdx1 and triggering b-cell failure [35], it is conceivable
that oxidative stress interacts with JNK, ATF3 and ER stress to
contribute to glucose/palmitate induced apoptosis, although this
hypothesis remains to be tested.
The role of SREBP1 in high glucose induced apoptosis in islet
b-cells has been reported [31]. In the absence of FFA, high glucose
alone for 48 hours was shown to activate SREBP1 and to repress
IRS2 and Pdx1 levels. Expression of a dominant negative SREBP1
reversed these transcriptional effects. In the current study, glucose
alone at high concentration slightly activated SREBP1 as shown in
Figure 4, an event that did not correlate with ER stress or
apoptosis. A much more significant activation of SREBP1 was
observed with glucose and palmitate together and this was shown
to be a function of induced ER stress since it was attenuated by
TUDCA (Figure 4C). These results only show an association of
SREBP1 nuclear translocation, and do not document its causal
role. It is likely however that SREBP1 nuclear translocation
participates in glucose/palmitate induced apoptosis, as previous
studies documented the causal role of SREBP1 in ER stress
induced apoptosis in insulinoma cells [31]. SREBP1 resides in the
ER membrane, where it is anchored by the labile protein INSIG1
[36]. The link between ER stress and SREBP1 activation has been
little studied. Lee et. al. using CHO cells [36] showed that
thapsigargin, a chemical that induces ER stress, activates SREBP1
due to rapid degradation of INSIG1 [36]. We observed that
glucose and palmitate together appeared to reduce INSIG1
protein (data not shown), which likely contributed to augmentation
of nuclear SREBP1 under these conditions.
Similarly a synergistic effect of glucose and FFA was observed on
expression of the ER-associated stress marker ATF3. ATF3
expression paralleled suppression of IRS2 protein levels, and
induction of apoptosis measured by CHOP (Figure 3A–B), and
Caspase3 activation (Figure 3A). The association of ATF3 with ER
stress and cell death has been well documented [37] but there is
relatively little known related to ATF3 targets [14]. Recently, ATF3
was shown to suppress the IRS2 protein by binding to the IRS2
promoter [14] and implicated this mechanism in apoptosis induced
by agents such as c-interferon, TNF-a, or thapsigargin. Our
findings are consistent with the involvement of ATF3 in the
apoptotic effects of nutrient induced ER stress in islet cells. In this
context, we note that Cunha et. al. [33] did not find a pro-apoptotic
role of ATF3 in the context of palmitate treatment. Potential
explanations for this apparent difference include the difference in
glucose concentration (25 mM glucose in our study and 11 mM
glucose in theirs), the cells used (INS-r3 in our study and INS-1E in
theirs), and assays (activated Caspase3 in our study and propidium
iodide plus Hoechst stain). An interesting question is whether ATF3
is a direct repressor of Pdx1 expression. Insulin signaling alters
Gsk3b and FoxO activity [16,32,38,39] and these proteins are
known regulators of Pdx1 expression. As ATF3 represses IRS2 and
insulin signaling, at least part of ER stress and ATF3 induced Pdx1
suppression is due to decreased insulin signaling, and perhaps also
due to direct suppression of Pdx1 expression, but this latter question
remains to be determined by future experiments. Interestingly
the islets and subjected to Western blot analysis using (A) anti-cleaved Caspase3 and anti-b-Actin, (B) anti-IRS2 antibodies, (C) anti-phospho-JNK,
anti-total JNK, anti-GRP78, anti-CHOP, anti-a-Tubulin antibodies, (D) anti-ATF3 antibodies, (E) anti-Acetyl CoA Carboxylase (ACC), anti-SREBP1, anti-a-
Tubulin antibodies, (F) anti-Pdx1, anti-phospho-Gsk3b, anti-total Gsk3b, anti-phospho-Akt (S473), anti-phospho-cJun, anti-a-Tubulin antibodies. The
blots shown are representative of 3 individual islet experiments. The relative ratio of indicated protein over b-Actin or a-Tubulin as a loading control
calculated by densitometries was summarized as means 6 S.E.M. in the graph respectively *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0018146.g005
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is part of signaling transduced by the membrane fatty acid
translocase CD36 and a role of CD36, which is induced by glucose,
has been proposed in mediating palmitate induced apoptosis of
kidney tubular epithelial cell [40]. The role of this pathway in islet
cells will need to be explored in future studies.
In the current studies we have shown a correlation among
suppression of IRS2 protein levels (Figure 2), ATF3 expression
(Figure 3), and resultant induction of apoptosis. The causal
relationships among these events were demonstrated by Li. et. al.
[14] when insulinoma cells and/or mouse islets were transfected with
adenoviruses expressing inducible gain- or loss-of-function of ATF3
Figure 6. Loss-of-function of ATF3 and gain-of function of IRS2 reduce the effects of glucose and palmitate on apoptosis. (A) INS-r3
cells were infected with either control or ATF3 shRNA adenovirus 24-h prior to treatment with 400 mM palmitate+0.5% BSA and 25 mM glucose for
the indicated times. Total cell lysates were obtained and subjected to Western blot analysis with antibodies to the indicated proteins. The relative
ratio of IRS2 and cleaved Caspase3 expression over b-Actin was quantified by densitometry. The data obtained from three individual experiments are
expressed as means 6 S.E.M. * p,0.02, ** p,0.012. (B) In a single experiment, primary mouse islets were infected with adenovirus expressing bgal or
IRS2 expressing adenovirus prior to treatment with either control 0.5% BSA and 5.5 mM glucose or 400 mM palmitate+0.5% BSA and 25 mM glucose
for 72-h. ‘‘GL’’ refers to incubation in 25 mM glucose and 400 mM palmitate. Total cell lysates were subjected to Western blot using antibodies to
indicated proteins.
doi:10.1371/journal.pone.0018146.g006
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PLoS ONE | www.plosone.org 11 April 2011 | Volume 6 | Issue 4 | e18146Figure 7. Inhibition of Gsk3b protects against glucose and palmitate-induced apoptosis in MIN6 cells. MIN6 cells were infected with
100, 200, or 400 MOI of adenovirus expressing a catalytically inactive mutant of the human Gsk3b (Adv-Gsk3bKM) or adenovirus expressing GFP (Adv-
GFP) 24 hours prior to palmitate treatment. Cells were treated with 25 mM glucose and with either 0.5% BSA or 400 mMP A +0.5% BSA for 24 hours. A
GFP control was placed on either end of the blot to facilitate comparison of control and Adv-Gsk3bKM. (A) Western blots using the indicated
antibodies, with relative expression of Pdx1 normalized over a-Tubulin, and expression levels of cleaved Caspase3 normalized over a-tubulin. (B)
Percentage of Propidium Iodide incorporation (n=3, means 6 S.E.M., *p,0.05, *** p,0.001).
doi:10.1371/journal.pone.0018146.g007
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suppression included induction of apoptosis by combined treatment
of insulinoma cells with c-interferon, TNF-a, or the ER stress
activator thapsigargin. These studies demonstrated that ATF3, like
the transcription factor CREB, alters IRS2 expression by binding to
the IRS2 promoter. In the current study, we have examined the role
of combined glucose and palmitate on this pathway (Figure 6).
Transduction with an adenovirus expressing shATF3 significantly
reduced this effect, while transduction with AdV-IRS2 ameliorated
the apoptotic effect, thus mechanistically linking this pathway.
In this study co-incubation of insulinoma cells with an adenovirus
expressing a kinase dead Gsk3b (Adv-Gsk3bKM, Figure 7) along
with high glucose and palmitate for 24 hours significantly reduced
cleavedCaspase3andcell death.A previousstudyinIRS2 nullmice
had demonstrated that the severe diabetes associated with markedly
increased apoptosis and reduced proliferation of islet b-cells was
reversed when crossed with Gsk3b haploinsufficient mice [32]. The
double knockout was also associated with enhanced expression of
Pdx1 in islet b-cells. Like the IRS2 null mice with severe insulin
resistance, glucose and FFA treatment of insulinoma cells and
primaryisletsinducesastateofinsulinresistance.AlsolikeIRS2null
mice on the Gsk3b genetic deficient background, reducing Gsk3b
activity with a kinase dead Gsk3b adenovirus restored Pdx1 levels
and reduced apoptosis and cell death. These findings emphasize the
contribution of impaired insulin receptor substrate signaling in the
apoptosis of b-cells treated with glucose and FFA, and the
contribution of Gsk3b activity to this process.
A schematic diagram highlights the key concepts implied by our
findings (Figure 8). In the insulin resistant subject abnormal
metabolism of FFA and glucose result in chronically high levels of
both nutrients in the circulation [41]. Under such conditions, the
combination of hyperglycemia and FFA has been suggested to be
particularly harmful for b-cells leading to so-called glucolipotoxicity
[6,42,43]. Our findings suggest that addition of high glucose to FFA
treated b-cells results in an escalating negative cycle. Under such
conditions activation of the transcription factor SREBP1 leads to
enhancedACCexpressionwithgenerationofmalonyl-CoA(MCC),
which impairs FFA oxidation. These in turn lead to ER stress with
further activation of SREBP1, ATF3, and impairment of FFA
oxidation. The excess unmetabolized FFA would partition in ER
membranes compounding ER stress. Additionally nuclear SREBP1
and ATF3 result in inhibition of IRS2, with concomitant
impairment of insulin receptor substrate signaling, increase of
Gsk3b activity and reduction of Pdx1 leading to apoptosis. Several
steps in the cycle shown in Figure 8 may be amenable to therapeutic
intervention. These include the impairment of FFA oxidation by
glucose, the synergistic effects of glucose and FFA on ER stress, the
activation of SREBP1 and its negative effects on insulin signaling,
and the downstream mediators of apoptosis that are activated by
reduced IRS-signaling involving both Gsk-3b and Fox01.
The results of the current studies illustrate some of the potential
mechanisms whereby a combination of high glucose and FFA, as
occurs in insulin resistant subjects, may result in eventual
destruction of b-cells. However, the ultimate contribution of these
mechanisms to the etiology of b-cell failure and diabetes remains
unknown and will need to be validated in vivo.
Author Contributions
Conceived and designed the experiments: MAP YT YL SCM CCM EBM
EZ TH NAA. Performed the experiments: KT YL CMW EZ. Analyzed
the data: KT YL SDH SCM CCM EBM YT CJR EZ TH NAA MAP.
Contributed reagents/materials/analysis tools: SCM CMW CJR EZ.
Wrote the paper: KT YL SDH CCM EBM YT TH NAA MAP.
References
1. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, et al. (2003) Beta-cell
deficit and increased beta-cell apoptosis in humans with type 2 diabetes.
Diabetes 52: 102–110.
2. Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A (2001) Beta-cell
adaptation and decompensation during the progression of diabetes. Diabetes 50
Suppl 1: S154–159.
3. Unger RH (2001) [Maurice Derot Prize 2001. The liporegulator system and
disease]. Journ Annu Diabetol Hotel Dieu. pp 129–143.
4. Donath MY, Halban PA (2004) Decreased beta-cell mass in diabetes:
significance, mechanisms and therapeutic implications. Diabetologia 47:
581–589.
5. Zhou YP, Grill VE (1994) Long-term exposure of rat pancreatic islets to fatty
acids inhibits glucose-induced insulin secretion and biosynthesis through a
glucose fatty acid cycle. J Clin Invest 93: 870–876.
6. Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and beta-cell
dysfunction. Endocr Rev 29: 351–366.
7. Cnop M (2008) Fatty acids and glucolipotoxicity in the pathogenesis of Type 2
diabetes. Biochem Soc Trans 36: 348–352.
8. Wrede CE, Dickson LM, Lingohr MK, Briaud I, Rhodes CJ (2002) Protein
kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-
1). J Biol Chem 277: 49676–49684.
9. Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, et al. (2004) Free
fatty acids and cytokines induce pancreatic beta-cell apoptosis by different
mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress.
Endocrinology 145: 5087–5096.
10. Cnop M, Ladriere L, Hekerman P, Ortis F, Cardozo AK, et al. (2007) Selective
inhibition of eukaryotic translation initiation factor 2 alpha dephosphorylation
potentiates fatty acid-induced endoplasmic reticulum stress and causes
pancreatic beta-cell dysfunction and apoptosis. J Biol Chem 282: 3989–3997.
11. Pirot P, Ortis F, Cnop M, Ma Y, Hendershot LM, et al. (2007) Transcriptional
regulation of the endoplasmic reticulum stress gene chop in pancreatic insulin-
producing cells. Diabetes 56: 1069–1077.
Figure 8. Working diagram illustrating some of the key steps
involved in ‘‘glucolipotoxicity’’ of b-cells. High glucose and FFA
together result in a vicious negative cycle that ultimately promotes b-
cell death. As suggested by our findings, high glucose addition to FFA
treated b-cells results in much more activation of SREBP1 than glucose
alone. SREBP1 enhances ACC expression with generation of malonyl-
CoA which impairs FFA oxidation. This in turn leads to augmented ER
stress with further activation of ER-localized SREBP1 as a result of
degradation of the anchoring protein Insig1. The excess non-
metabolized FFA due to more impairment of FFA oxidation would
partition in ER membranes compounding ER stress. In addition to
SREBP1, ER stress activates ATF3. Both nuclear SREBP1 and ATF3 result
in inhibition of IRS2, with concomitant impairment of insulin signaling,
activation of Gsk3b and reduction of Pdx1 leading to apoptosis.
doi:10.1371/journal.pone.0018146.g008
Glucolipotoxicity Mechanisms
PLoS ONE | www.plosone.org 13 April 2011 | Volume 6 | Issue 4 | e1814612. Laybutt DR, Preston AM, Akerfeldt MC, Kench JG, Busch AK, et al. (2007)
Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2
diabetes. Diabetologia 50: 752–763.
13. Bachar E, Ariav Y, Ketzinel-Gilad M, Cerasi E, Kaiser N, et al. (2009) Glucose
amplifies fatty acid-induced endoplasmic reticulum stress in pancreatic beta-cells
via activation of mTORC1. PLoS ONE 4: e4954.
14. Li D, Yin X, Zmuda EJ, Wolford CC, Dong X, et al. (2008) The repression of
IRS2 gene by ATF3, a stress-inducible gene, contributes to pancreatic beta-cell
apoptosis. Diabetes 57: 635–644.
15. Hai T, Hartman MG (2001) The molecular biology and nomenclature of the
activating transcription factor/cAMP responsive element binding family of
transcription factors: activating transcription factor proteins and homeostasis.
Gene 273: 1–11.
16. Martinez SC, Tanabe K, Cras-Meneur C, Abumrad NA, Bernal-Mizrachi E,
et al. (2008) Inhibition of Foxo1 protects pancreatic islet beta-cells against fatty
acid and endoplasmic reticulum stress-induced apoptosis. Diabetes 57: 846–859.
17. Ishihara H, Asano T, Tsukuda K, Katagiri H, Inukai K, et al. (1993) Pancreatic
beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-
stimulated insulin secretion similar to those of normal islets. Diabetologia 36:
1139–1145.
18. Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, et al. (2000)
Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-
dependent and -independent glucose-stimulated insulin secretion. Diabetes 49:
424–430.
19. Girish V, Vijayalakshmi A (2004) Affordable image analysis using NIH Image/
ImageJ. Indian J Cancer 41: 47.
20. Bernal-Mizrachi E, Fatrai S, Johnson JD, Ohsugi M, Otani K, et al. (2004)
Defective insulin secretion and increased susceptibility to experimental diabetes
are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest
114: 928–936.
21. Finlay D, Patel S, Dickson LM, Shpiro N, Marquez R, et al. (2004) Glycogen
synthase kinase-3 regulates IGFBP-1 gene transcription through the thymine-
rich insulin response element. BMC Mol Biol 5: 15.
22. Srinivasan S, Bernal-Mizrachi E, Ohsugi M, Permutt MA (2002) Glucose
promotes pancreatic islet beta-cell survival through a PI 3-kinase/Akt-signaling
pathway. Am J Physiol Endocrinol Metab 283: E784–793.
23. White MF (2002) IRS proteins and the common path to diabetes. Am J Physiol
Endocrinol Metab 283: E413–422.
24. Srinivasan S, Ohsugi M, Liu Z, Fatrai S, Bernal-Mizrachi E, et al. (2005)
Endoplasmic reticulum stress-induced apoptosis is partly mediated by reduced
insulin signaling through phosphatidylinositol 3-kinase/Akt and increased
glycogen synthase kinase-3beta in mouse insulinoma cells. Diabetes 54: 968–975.
25. Hartman MG, Lu D, Kim ML, Kociba GJ, Shukri T, et al. (2004) Role for
activating transcription factor 3 in stress-induced beta-cell apoptosis. Mol Cell
Biol 24: 5721–5732.
26. Ramalho RM, Viana RJ, Low WC, Steer CJ, Rodrigues CM (2008) Bile acids
and apoptosis modulation: an emerging role in experimental Alzheimer’s
disease. Trends Mol Med 14: 54–62.
27. Shimano H (2007) SREBP-1c and TFE3, energy transcription factors that
regulate hepatic insulin signaling. J Mol Med 85: 437–444.
28. Goldstein JL, DeBose-Boyd RA, Brown MS (2006) Protein sensors for
membrane sterols. Cell 124: 35–46.
29. Kakuma T, Lee Y, Higa M, Wang Z, Pan W, et al. (2000) Leptin, troglitazone,
and the expression of sterol regulatory element binding proteins in liver and
pancreatic islets. Proc Natl Acad Sci U S A 97: 8536–8541.
30. Takahashi A, Motomura K, Kato T, Yoshikawa T, Nakagawa Y, et al. (2005)
Transgenic mice overexpressing nuclear SREBP-1c in pancreatic beta-cells.
Diabetes 54: 492–499.
31. Wang H, Kouri G, Wollheim CB (2005) ER stress and SREBP-1 activation are
implicated in beta-cell glucolipotoxicity. J Cell Sci 118: 3905–3915.
32. Tanabe K, Liu Z, Patel S, Doble BW, Li L, et al. (2008) Genetic deficiency of
glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin
resistance. PLoS Biol 6: e37.
33. Cunha DA, Hekerman P, Ladriere L, Bazarra-Castro A, Ortis F, et al. (2008)
Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J Cell Sci
121: 2308–2318.
34. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, et al. (2000) Coupling of
stress in the ER to activation of JNK protein kinases by transmembrane protein
kinase IRE1. Science 287: 664–666.
35. Kawamori D, Kaneto H, Nakatani Y, Matsuoka TA, Matsuhisa M, et al. (2006)
The forkhead transcription factor Foxo1 bridges the JNK pathway and the
transcription factor PDX-1 through its intracellular translocation. J Biol Chem
281: 1091–1098.
36. Lee JN, Ye J (2004) Proteolytic activation of sterol regulatory element-binding
protein induced by cellular stress through depletion of Insig-1. J Biol Chem 279:
45257–45265.
37. Lu D, Chen J, Hai T (2007) The regulation of ATF3 gene expression by
mitogen-activated protein kinases. Biochem J 401: 559–567.
38. Altomonte J, Richter A, Harbaran S, Suriawinata J, Nakae J, et al. (2003)
Inhibition of Foxo1 function is associated with improved fasting glycemia in
diabetic mice. Am J Physiol Endocrinol Metab 285: E718–728.
39. Accili D, Arden KC (2004) FoxOs at the crossroads of cellular metabolism,
differentiation, and transformation. Cell 117: 421–426.
40. Susztak K, Ciccone E, McCue P, Sharma K, Bottinger EP (2005) Multiple
metabolic hits converge on CD36 as novel mediator of tubular epithelial
apoptosis in diabetic nephropathy. PLoS Med 2: e45.
41. Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, et al. (1995) A
high concentration of fasting plasma non-esterified fatty acids is a risk factor for
the development of NIDDM. Diabetologia 38: 1213–1217.
42. El-Assaad W, Buteau J, Peyot ML, Nolan C, Roduit R, et al. (2003) Saturated
fatty acids synergize with elevated glucose to cause pancreatic beta-cell death.
Endocrinology 144: 4154–4163.
43. Prentki M, Joly E, El-Assaad W, Roduit R (2002) Malonyl-CoA signaling, lipid
partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the
etiology of diabetes. Diabetes 51 Suppl 3: S405–413.
Glucolipotoxicity Mechanisms
PLoS ONE | www.plosone.org 14 April 2011 | Volume 6 | Issue 4 | e18146